Fox Chase Cancer Center News

Fox Chase and Temple Health Clinicians Appointed to New Positions With International Mesothelioma Interest Group

PHILADELPHIA (October 16, 2023) — Joseph Friedberg, MD, FACS, Thoracic Surgeon-In-Chief for Temple Health, Professor of Thoracic Medicine and Surgery, Professor in the Division of Thoracic Surgery at Fox Chase Cancer Center, and Melissa Culligan, RN, BSN, MSc, PhD candidate, Director of Thoracic Surgery Research in the Department of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University, were recently appointed to new positions in the International Mesothelioma Interest Group (iMig).
VIEW STORY

Temple Health, Fox Chase Dietitians Present at Academy of Nutrition and Dietetics’ Food & Nutrition Conference & Expo

PHILADELPHIA (October 13, 2023) — Jaylin Kellogg, MS, RD, LDN, CNSC, Nutrition Support Dietitian, and Kara Stromberg, MS, RD, CDE, LDN, Clinical Nutrition Manager, both at Fox Chase Cancer Center and Temple University Hospital - Jeanes Campus, presented information regarding the role of dietitians in end-of-life care at this year’s Academy of Nutrition and Dietetics’ Food & Nutrition Conference & Expo (FNCE).
VIEW STORY

Dogs, Downpours, and Dedication at ‘Paws for the Cause’ 2023

Cancer doesn’t stop, and neither do we. This was the sentiment amid gray skies and wet, rainy conditions at the 24th Annual Paws for the Cause Dog Walk, held September 10, 2023 at Fox Chase Cancer Center. The event raised more than $115,000 for cancer research and postdoctoral support at Fox Chase.
VIEW STORY

Fox Chase Cancer Center and Lewis Katz School of Medicine at Temple University Researchers Will Be Principal Investigators on a New Epidemiological Study of Asian Americans

PHILADELPHIA (October 2, 2023) — Researchers from Fox Chase Cancer Center and the Lewis Katz School of Medicine at Temple University will serve as two of the principal investigators on the Asian American Community Cohort and Equity Study, which is part of a new seven-year epidemiological cohort study of Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI).
VIEW STORY

Fox Chase Researcher Presents Findings on 5-Aminolevulinic Acid-Mediated Radiation Therapy to Reduce Tumor Size at American Society for Radiation Oncology Meeting

PHILADELPHIA (October 2, 2023) — Radiodynamic therapy at specific energy levels help effectively reduce tumor size in combination with the amino acid 5-aminolevulinic acid, according to findings presented by a Fox Chase Cancer Center researcher recently at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Diego.
VIEW STORY